Xenglu-Lin [Empagliflozin+Linagliptin] 10mg/5mg tablets

Xenglu-Lin (Empagliflozin 10mg + Linagliptin 5mg) Tablets

Dual-Action Blood Sugar Control for Type 2 Diabetes

Xenglu-Lin is a combination of Empagliflozin (SGLT2 inhibitor) and Linagliptin (DPP-4 inhibitor) that helps lower blood sugar levels in adults with type 2 diabetes. This dual-action formula works by reducing glucose reabsorption in the kidneys and increasing insulin secretion, leading to improved glycemic control while supporting heart and kidney health.

Key Benefits

✔ Effectively Lowers Blood Sugar Levels – Dual mechanism for better glucose control.
✔ Supports Weight Management & Blood Pressure Control – Helps with overall metabolic health.
✔ Reduces Risk of Heart & Kidney Complications – Provides additional cardiovascular and renal benefits.
✔ Works Independently of Insulin – Can be used alone or with other diabetes medications.
✔ Once-Daily Dosage – Ensures convenient and long-lasting blood sugar regulation.

How to Use

• Take one tablet daily, or as prescribed by your doctor.
• Swallow whole with water; do not crush or chew.
• Can be taken with or without food.
• Follow a healthy diet and exercise routine for best results.

Important Information

• Stay hydrated to prevent dehydration due to increased urination.
• Monitor blood sugar, kidney function, and overall health regularly.
• May cause urinary tract or genital infections; consult a doctor if symptoms appear.
• Not recommended for individuals with severe kidney disease.
• Consult your doctor before use if taking other diabetes medications.

Xenglu-Lin is an effective combination therapy for type 2 diabetes management, helping patients achieve better blood sugar control while reducing the risk of long-term complications.